Buy Sobha, SRF, Ajanta Pharma, HDFC: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Real Estate has done well. So, Sobha has restarted its rally. It is a buy with a stop loss of Rs 300, look for targets of Rs 321.""SRF is moving very strongly, it has held its 20-day moving average (DMA) on the upside. It is a buy with a stop loss of Rs 1,360, target of Rs 1,425 and Ajanta Pharma also from its 20-DMA is now moving higher. It is a buy with a stop loss of Rs 1,490 for target of Rs 1,550," he said."HDFC is just getting out of jail and you could still have targets of Rs 1,300-1,320. So, this is the time to get in. Once something starts to show the momentum on the upside and this basically got hammered, got exhausted on the down side, now everybody is feeling positive about it. So, probably more upside to go for HDFC from here. So, it would still qualify as a buy on dip."